Kate L. Weeks

75 Commercial Road
Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Targeted glycophagy ATG8 therapy reverses diabetic heart disease in mice and in human engineered cardiac tissues.

Targeted glycophagy ATG8 therapy reverses diabetic heart disease in mice and in human engineered cardiac tissues.

Journal: bioRxiv : the preprint server for biology

Published: October 03, 2025

Methods for detection of cardiac glycogen-autophagy.

Methods for detection of cardiac glycogen-autophagy.

Journal: Autophagy reports

Published: May 21, 2025

An IL6 variant -174 G-C alters cardiac hypertrophy but not cardiometabolic responses to HFD in mice.

An IL6 variant -174 G-C alters cardiac hypertrophy but not cardiometabolic responses to HFD in mice.

Journal: npj metabolic health and disease

Published: April 22, 2025

PP2A-B56α is a key determinant of cardiac protein phosphorylation and functional responses to β-adrenergic signalling.

PP2A-B56α is a key determinant of cardiac protein phosphorylation and functional responses to β-adrenergic signalling.

Journal: Journal of molecular and cellular cardiology plus

Published: February 14, 2025

Generation and evaluation of a novel PI3K-targeting gene therapy in the failing mouse heart and healthy sheep heart.

Generation and evaluation of a novel PI3K-targeting gene therapy in the failing mouse heart and healthy sheep heart.

Journal: Journal of molecular and cellular cardiology plus

Published: January 17, 2025

Targeted glycophagy ATG8 therapy reverses diabetic heart disease in mice and in human engineered cardiac tissues.

Targeted glycophagy ATG8 therapy reverses diabetic heart disease in mice and in human engineered cardiac tissues.

Journal: Nature cardiovascular research

Published: November 27, 2024

Lipidomic Profiling of a Preclinical Model of Streptozotocin-Induced Diabetic Cardiomyopathy Reveals Potential Plasma Biomarkers.

Lipidomic Profiling of a Preclinical Model of Streptozotocin-Induced Diabetic Cardiomyopathy Reveals Potential Plasma Biomarkers.

Journal: Heart, lung & circulation

Published: November 25, 2024

Cardiomyocyte-Specific FoxO1 Knockout Mice as Tools to Assess Cardiac Hypertrophy and Key Experimental Considerations Using Cre-loxP.

Cardiomyocyte-Specific FoxO1 Knockout Mice as Tools to Assess Cardiac Hypertrophy and Key Experimental Considerations Using Cre-loxP.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: November 20, 2024

New insights into diabetes-induced cardiac pathology.

New insights into diabetes-induced cardiac pathology.

Journal: Journal of molecular and cellular cardiology

Published: November 15, 2024

Adeno-Associated Viruses as Gene Delivery Tools for Diabetic Heart Disease and Failure: Key Considerations for Clinicians and Preclinical Researchers.

Adeno-Associated Viruses as Gene Delivery Tools for Diabetic Heart Disease and Failure: Key Considerations for Clinicians and Preclinical Researchers.

Journal: Heart, lung & circulation

Published: September 19, 2024

Methods for detection of cardiac glycogen-autophagy.

Methods for detection of cardiac glycogen-autophagy.

Journal: bioRxiv : the preprint server for biology

Published: August 30, 2024

Reduced PI3K(p110α) induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation.

Reduced PI3K(p110α) induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation.

Journal: Journal of sport and health science

Published: July 19, 2024

Showing 1-12 of 57

Last Updated: 09/26/2026